Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NephroGenex Inc (NASDAQ:NRX)

0.92
Delayed Data
As of Feb 05
 -0.05 / -5.15%
Today’s Change
0.77
Today|||52-Week Range
9.01
-42.50%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close0.97
Today’s open0.94
Day’s range0.86 - 0.94
Volume105,637
Average volume (3 months)209,227
Market cap$12.6M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)-7.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.44

Competitors

 Today’s
change
Today’s
% change
MCPIMCPI Inc-0.00-5.44%
CBAYCymaBay Therapeutics...-0.08-6.20%
DITAMCON Distributing C...0.000.00%
BIOSBioScrip Inc-0.04-2.50%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 22, 2016
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Pierre Legault
Chief Financial Officer, Secretary &
Treasurer
John P. Hamill
Corporate headquarters
Durham, North Carolina

Forecasts

Partner Offers